Predictive Oncology

$1.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (+5.08%) As of 7:03 PM UTC today

Why Robinhood?

You can buy or sell POAI and other stocks, options, and ETFs commission-free!

About POAI

Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Domestic, International, and Helomics. The Domestic and International segments focuses on STREAMWAY System product sales. The Helomics segment comprises of clinical testing and contract research. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN. The listed name for POAI is Predictive Oncology Inc. Common Stock.

CEO
Carl Schwartz
Employees
32
Headquarters
Eagan, Minnesota
Founded
2002
Market Cap
57.48M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.24M
High Today
$1.46
Low Today
$1.20
Open Price
$1.26
Volume
3.74M
52 Week High
$4.42
52 Week Low
$0.63

POAI Earnings

-$1.45
-$0.97
-$0.48
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 31, After Hours

You May Also Like

FTF
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure